This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Prophylactic surgery
Z21_PROPHYLACT_SURGE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
269 |
4. Check minimum number of eventsNone |
269 |
5. Include endpointsNone |
269 |
6. Filter based on genotype QC (FinnGen only) |
269 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z4|Z5[0-4]
Similar endpoints
↥List of similar endpoints to
Prophylactic surgery
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 269 | 251 | 18 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.01 |
| Median age at first event (years) | 46.01 | 45.72 | 50.00 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 232
- Matched controls
- 2318
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
+∞
247.4
191
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
294.6
146.2
136
11
Z31.5
ICD-10 Finland
Genetic counselling
37.4
94.3
125
70
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
35.3
78.6
104
52
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
93.9
67.0
72
11
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
20.3
67.0
108
95
HA1AA
NOMESCO Finland
X-ray mammography
19.8
64.2
104
91
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
130.6
63.8
66
7
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
+∞
63.5
58
*
HAE99
NOMESCO Finland
Other reconstruction of breast
267.8
61.3
60
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
55.0
59.7
70
18
115
Kela drug reimbursment
Breast cancer
15.4
54.5
98
105
R4110
NOMESCO Finland
Physiotherapy
9.7
53.6
144
334
HAC20
NOMESCO Finland
Total mastectomy
32.9
49.3
65
27
WX404
NOMESCO Finland
Intravenous generell anesthesy
8.4
46.5
132
313
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
19.2
46.2
73
54
TQW20
NOMESCO Finland
Tatoe
53.5
45.9
54
13
H02AB02
ATC
dexamethasone; systemic
13.4
44.3
83
92
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
57.5
43.1
50
11
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
254.7
42.4
42
*
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
418.7
37.1
36
*
L02BA01
ATC
tamoxifen; oral
18.5
36.1
57
40
TQB05
NOMESCO Finland
Puncture of skin of trunk
92.8
36.1
39
5
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
20.9
35.9
54
33
PJA12
NOMESCO Finland
Sentinel node biopsy
10.2
35.4
76
105
ZXD10
NOMESCO Finland
Scheduled procedure
5.9
35.0
153
572
WX402
NOMESCO Finland
General anaesthesia
6.9
33.7
101
233
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
136.6
33.7
35
*
WX408
NOMESCO Finland
General anesthesy, balanced
6.0
32.4
115
327
A03FA01
ATC
metoclopramide; systemic, rectal
6.3
32.2
105
268
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
31.7
31.9
42
16
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
79.1
30.8
34
5
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
12.7
30.7
57
58
ZXE10
NOMESCO Finland
More than one and less than three hours
5.2
30.5
142
537
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
123.0
30.5
32
*
ZXA00
NOMESCO Finland
Right side
5.8
30.3
109
309
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
76.4
29.8
33
5
B01AB05
ATC
enoxaparin; parenteral
5.3
29.3
120
391
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
56.5
29.3
34
7
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
17.9
27.3
43
29
Z2221
NOMESCO Finland
Medical doctor
4.8
26.9
127
469
ZZF00
NOMESCO Finland
Graft of adipose tissue
46.0
26.6
32
8
Z40.8
ICD-10 Finland
Other prophylactic surgery
+∞
26.6
25
*
ZXA05
NOMESCO Finland
Left side
5.3
26.4
98
279
ZXE40
NOMESCO Finland
More than seven and less than nine hours
40.9
26.0
32
9
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
13.6
25.0
44
39
ZXE30
NOMESCO Finland
More than five and less than seven hours
16.4
24.7
40
29
ZZR10
NOMESCO Finland
Flap of skin and muscle
63.3
24.6
28
5
Z3231
NOMESCO Finland
Registered nurse
4.9
24.6
101
316
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
47.0
24.2
29
7
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
72.7
23.3
26
*
C50.99
ICD-10 Finland
Breast, unspecified
20.7
23.0
34
19
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
69.6
22.3
25
*
A04AA02
ATC
granisetron; systemic, transdermal
10.8
22.3
44
49
Z3226
NOMESCO Finland
Physiotherapist
5.4
22.3
77
196
ZXE20
NOMESCO Finland
More than three and less than five hours
6.6
21.8
61
119
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
22.1
21.5
31
16
HAD20
NOMESCO Finland
Liposuction of breast
217.6
19.9
20
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
14.0
19.8
34
28
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
29.0
19.6
26
10
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
6.2
19.0
55
111
ZXA10
NOMESCO Finland
Bilateral
4.6
18.2
73
212
A04AA01
ATC
ondansetron; systemic, rectal
9.4
18.1
38
47
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
4.4
17.9
76
233
ZXE00
NOMESCO Finland
One hour or less
3.4
17.5
134
663
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.4
17.2
135
680
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
8.5
17.1
38
52
JN4BD
NOMESCO Finland
Extensive body CT
7.1
16.9
43
72
Z40.9
ICD-10 Finland
Prophylactic surgery, unspecified
+∞
16.9
16
*
A04AA55
ATC
palonosetron, combinations; systemic
9.9
16.4
33
38
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
91.3
15.8
17
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.2
15.7
39
63
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
10.0
15.5
31
35
A04AD12
ATC
aprepitant; systemic
16.6
15.2
24
16
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
+∞
14.7
14
*
L03AA13
ATC
pegfilgrastim; parenteral
9.0
14.6
31
39
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
45.6
14.3
17
*
1CD02
NOMESCO Finland
NA
32.3
14.1
18
6
L02BG04
ATC
letrozole; oral
5.8
14.1
41
82
N02BE01
ATC
paracetamol; systemic, rectal
5.5
13.7
218
1710
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
27.7
13.6
18
7
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
27.7
13.6
18
7
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
42.7
13.3
16
*
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
6.9
13.2
33
54
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
30.4
13.1
17
6
WX110
NOMESCO Finland
Local anesthesy
3.3
12.9
192
1369
ZX120
NOMESCO Finland
Intravenous
5.7
12.7
37
74
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
21.5
12.7
18
9
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
+∞
12.6
12
*
R4120
NOMESCO Finland
Occupational therapy
6.7
12.5
32
54
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.9
12.0
30
49
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
31.9
11.8
15
5
ZXM40
NOMESCO Finland
Use of fluorescent substance
+∞
11.5
11
*
TQW99
NOMESCO Finland
Other minor procedure on skin
7.1
11.5
28
44
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
16.1
11.5
18
12
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
8.8
11.4
24
30
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
18.2
11.4
17
10
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
21.3
11.3
16
8
QBJ00
NOMESCO Finland
Liposuction in trunk
26.5
11.3
15
6
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
26.5
11.3
15
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
7.0
11.0
27
43
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
18.9
10.9
16
9
ZXD20
NOMESCO Finland
Day surgery
3.7
10.8
50
159
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
22.8
10.8
15
7
R2110
NOMESCO Finland
Giving the first information
4.7
10.8
37
89
N64.9
ICD-10 Finland
Disorder of breast, unspecified
15.2
10.7
17
12
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
15.2
10.7
17
12
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
7.2
10.5
25
38
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
19.9
10.4
15
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
10.2
85
405
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
21.1
9.9
14
7
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.2
9.8
26
46
HAB40
NOMESCO Finland
Wedge excision of mammary gland
5.5
9.8
29
59
L02BG06
ATC
exemestane; oral
12.1
9.7
17
15
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
8.1
9.7
21
28
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
18.5
9.5
14
8
ZZS50
NOMESCO Finland
Insertion of tissue expander
104.0
9.5
10
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
4.9
9.5
31
71
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
22.8
9.5
13
6
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
10.2
9.4
18
19
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
38.3
9.1
11
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
51.9
8.7
10
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.8
8.7
24
45
L01BC06
ATC
capecitabine; oral
8.4
8.5
18
23
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.6
8.4
24
47
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
8.4
8
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
4.7
8.4
28
66
ZXD05
NOMESCO Finland
Urgent procedure
2.4
8.1
90
489
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
13.7
8.0
13
10
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.7
7.8
26
61
Z50.1
ICD-10 Finland
Other physical therapy
46.5
7.8
9
*
C50
ICD-10 Finland
Malignant neoplasm of breast
7.1
7.8
18
27
ZX112
NOMESCO Finland
Subcutaneous
12.4
7.7
13
11
L02AE03
ATC
goserelin; implant
9.3
7.7
15
17
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
26.0
7.6
10
*
B01AB04
ATC
dalteparin; parenteral
5.1
7.6
23
49
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
14.0
7.5
12
9
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
14.0
7.5
12
9
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
82.6
7.5
8
*
J01DB01
ATC
cefalexin; oral
2.8
7.4
205
1687
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
+∞
7.3
7
*
HAD99
NOMESCO Finland
Other plastic operation on breast
16.4
7.3
11
7
S18
ICPC
Laceration/cut
2.2
7.3
95
553
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
6.0
7.2
19
34
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.4
6.7
23
56
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.2
6.7
14
18
N63
ICD-10 Finland
Unspecified lump in breast
3.5
6.5
29
90
ZZS55
NOMESCO Finland
Distension of tissue expander
71.7
6.5
7
*
HAD00
NOMESCO Finland
Augmentation mammoplasty
71.7
6.5
7
*
M05BX04
ATC
denosumab; parenteral
8.5
6.4
13
16
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
6.3
6
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
6.2
84
489
X76
ICPC
Malignant neoplasm breast female
7.6
6.0
13
18
SPAT1324
SPAT
Screening procedure
0.4
6.0
21
508
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
102
161
9.59
67.35
3.1
4.2
ug/l
5.2
7.3
0.25
65
124
(3002256) Pathology report gross observation
119
305
6.20
47.51
1.9
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
178
668
5.92
45.26
2.6
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
145
503
5.08
39.26
2.1
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
32
27
13.32
32.22
1.1
1.1
—
—
—
0
0
(4035726)
71
172
5.25
28.76
1.5
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
54
104
6.25
28.06
7.1
5.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
48
85
6.66
27.08
1.4
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
44
75
6.82
25.70
8.0
5.3
mmol/l
24.1
24.7
0.62
44
75
(40768804) Tissue Pathology biopsy report
188
999
3.93
24.53
3.0
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
191
1031
3.94
24.21
3.9
3.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
34
50
7.64
22.64
2.4
3.2
u/ml
11.0
2615.0
0.49
29
45
(3003396) Base excess in Arterial blood by calculation
57
143
4.79
21.78
7.1
5.9
mmol/l
-0.4
0.6
1.67
52
119
(3014007) Fractional oxyhemoglobin in Arterial blood
44
89
5.72
21.50
8.1
6.6
%
96.0
94.3
1.69
44
89
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
44
90
5.65
21.23
8.0
6.6
%
1.0
0.7
2.87
44
90
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
43
89
5.56
20.46
8.2
6.6
%
1.4
1.3
0.05
43
89
(4281824)
22
23
10.33
19.03
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
129
621
3.07
18.12
7.4
2.7
mmol/l
2.4
2.4
2.34
121
560
(40758558) Short blood count panel - Blood
116
534
3.06
17.53
9.9
6.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
70
240
3.59
17.20
2.2
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
147
797
2.86
16.08
5.6
4.3
mmol/l
1.2
1.2
5.14
136
729
(3044889) 12 lead EKG panel
207
1383
3.16
14.71
3.4
3.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
154
884
2.74
14.64
6.3
4.8
mmol/l
1.2
1.2
6.42
136
761
(3023368) Bacteria identified in Blood by Culture
81
346
2.92
13.48
3.3
3.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
183
1224
2.55
11.56
11.1
7.9
e9/l
3.6
3.8
0.90
158
1073
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
49
5.28
11.44
1.4
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
54
206
3.03
10.82
2.0
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
101
531
2.44
10.73
3.3
3.1
ph
7.4
7.4
—
9
88
(4306422)
18
34
5.60
9.29
1.1
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
251
2066
4.21
9.21
22.7
12.4
g/l
330.4
331.8
1.85
251
2055
(3030467) Casts [#/volume] in Urine by Automated count
90
477
2.33
9.16
3.0
2.5
e6/l
0.1
0.4
1.51
59
343
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
57
251
2.61
8.62
2.9
2.4
e6/l
3.8
4.1
0.07
30
129
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
21
49
4.56
8.57
1.4
1.8
g/l
3.4
3.5
0.12
21
49
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
60
276
2.51
8.27
2.9
2.3
e6/l
0.9
1.1
0.13
31
153
(3002582) Erythrocytes [#/volume] in Urine
93
521
2.20
8.14
3.0
2.6
e6/l
52.7
54.4
0.02
65
378
(3013826) Glucose [Moles/volume] in Serum or Plasma
155
1063
2.08
7.89
4.8
3.4
mmol/l
6.5
6.3
0.44
148
962
(3003694) ABO and Rh group [Type] in Blood
113
691
2.10
7.83
1.4
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
87
486
2.17
7.59
3.0
2.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
109
666
2.07
7.50
3.5
3.0
e6/l
43.9
74.3
0.60
66
424
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
38
4.71
7.29
1.1
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
42
177
2.63
6.87
2.5
2.3
u/l
32.3
32.9
0.04
35
155
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
111
705
1.98
6.69
3.1
2.9
u/l
28.1
28.9
0.20
106
684
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
65
3.60
6.57
4.0
8.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
263
2405
5.19
6.09
17.0
10.2
umol/l
66.6
67.2
0.19
263
2405
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
16
6.45
6.00
1.1
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
246
2133
2.79
5.60
13.2
8.1
ml/min/173m2
90.7
88.6
0.89
215
1704
(4268621)
12
26
4.78
5.31
2.2
2.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
41
3.82
5.00
1.1
1.1
u/ml
8.3
3.4
—
6
14
(3052851) Hemolysis interference index of Serum or Plasma
18
57
3.31
4.86
1.2
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
247
2177
2.65
4.85
22.2
10.3
%
38.9
39.9
2.52
228
1768
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
255
2285
3.23
4.82
14.6
9.2
mg/l
26.5
18.3
3.48
228
1716
(3026782) Osmolality of Urine
58
331
1.96
4.55
2.2
2.2
mosm/kgh2o
537.0
554.3
0.19
48
283
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
77
485
1.82
4.46
1.5
1.6
mg/l
0.8
0.8
0.10
56
372
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
51
280
2.01
4.46
2.9
2.9
ng/l
69.2
538.4
0.99
31
167
(3034426) Prothrombin time (PT)
7
6
11.93
4.30
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
39
3.45
3.81
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
59
361
1.81
3.71
2.2
2.1
e6/l
10.9
7.2
0.63
48
311
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
36
3.44
3.52
1.2
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
36
3.44
3.52
1.2
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
33
176
2.00
3.12
3.0
3.5
mmol/l
1.0
1.0
0.58
33
163
(3029937) Albumin [Presence] in Urine by Test strip
34
579
0.53
3.09
2.7
3.2
estimate
0.0
0.0
—
8
199
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
8
7.64
3.07
1.2
1.0
%
108.5
143.7
—
6
8
(3032080) INR in Blood by Coagulation assay
85
604
1.60
3.03
7.8
5.4
inr
1.1
1.1
0.07
17
186
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
5
5
10.15
2.99
1.4
3.6
%
91.2
106.2
—
5
5
(3021879) Hepatitis B virus core Ab [Presence] in Serum
33
181
1.94
2.89
1.3
1.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
9
6.79
2.88
1.3
2.4
%
91.0
120.4
—
6
9
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
14
5.10
2.74
1.9
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
89
653
1.54
2.72
4.2
5.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
67
2.48
2.69
1.1
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
168
1415
1.50
2.60
4.1
3.6
—
882.7
—
0
16
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
277
1.70
2.49
1.2
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
12
5.09
2.41
1.2
1.5
%
101.7
103.3
—
6
12
(3026008) Bacteria identified in Urine by Culture
79
588
1.49
2.20
2.7
2.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
116
930
1.43
2.20
4.6
5.3
%
0.7
0.7
0.27
109
868
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
24
3.40
2.20
2.5
1.9
u/ml
3.0
3.6
—
8
19
(3012544) pH of Venous blood
22
116
1.98
2.18
1.6
2.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
14
4.36
2.16
1.3
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
26
148
1.84
2.07
1.5
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
132
1092
1.41
2.06
5.4
5.3
e9/l
1.9
1.9
0.55
114
984
(3006504) Eosinophils/100 leukocytes in Blood
120
977
1.41
2.05
4.6
5.2
%
2.5
2.8
0.80
112
913
(3035637) Corticotropin [Mass/volume] in Plasma
6
15
4.07
2.05
1.2
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
32
2.87
2.02
1.3
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
128
1057
1.40
2.01
5.4
5.4
e9/l
0.0
0.0
0.89
107
933
(3002030) Lymphocytes/100 leukocytes in Blood
124
1019
1.40
2.00
4.5
5.2
%
29.9
30.0
0.02
116
956
(36660697) Celiac disease serology panel - Serum
32
197
1.71
1.98
1.3
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
120
982
1.40
1.97
4.7
5.4
%
8.0
8.0
0.06
113
924
(3018010) Neutrophils/100 leukocytes in Blood
123
1012
1.40
1.96
4.6
5.0
%
56.0
56.0
0.01
116
953
(3049717) Cytology report of Urine Cyto stain
11
45
2.51
1.95
3.2
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
127
1053
1.39
1.92
5.4
5.3
e9/l
0.5
0.5
0.22
107
933
(3011397) Hemoglobin [Presence] in Urine by Test strip
66
487
1.47
1.90
2.7
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
160
1.76
1.90
2.6
1.9
ml/min/173m2
84.0
79.8
0.19
11
66
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
22
3.24
1.89
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
257
2444
2.16
1.89
12.0
8.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
90
707
1.41
1.85
1.9
1.8
pmol/l
104.5
100.8
0.47
45
361
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
17
3.58
1.85
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
12
4.22
1.83
1.0
1.9
umol/l
8.2
9.3
—
5
12
(40761536) Microorganisms panel - Urine sediment
8
177
0.44
1.77
1.9
2.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
25
149
1.75
1.74
1.5
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
24
2.97
1.73
1.0
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
24
2.97
1.73
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
44
306
1.52
1.68
3.0
2.2
mmol/l
2.5
2.4
1.62
38
276
(3013512) EKG study
34
498
0.64
1.68
3.0
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
112
926
1.36
1.66
2.5
2.2
nmol/l
78.0
75.7
0.43
104
863
(3002179) Metamyelocytes/100 leukocytes in Blood
5
134
0.36
1.66
1.4
3.9
—
0.9
—
0
28
(3021589) Normoblasts [#/volume] in Blood
112
931
1.35
1.59
6.2
7.2
e9/l
0.0
0.0
0.69
76
768
(40760892) CBC W Ordered Manual Differential panel - Blood
39
548
0.66
1.58
3.4
4.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
117
1.77
1.49
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
20
117
1.77
1.49
1.2
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
73
1.97
1.46
1.6
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
16
3.16
1.44
1.2
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
20
121
1.71
1.35
1.2
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
128
1105
1.30
1.34
5.7
5.8
e9/l
0.2
0.2
0.13
111
990
(3026493) Urate [Moles/volume] in Serum or Plasma
62
483
1.37
1.31
1.9
2.1
umol/l
7481.5
5195.5
0.12
54
436
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
23
147
1.62
1.28
3.4
3.6
u/l
241.6
224.1
0.49
23
142
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
100
1.75
1.26
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
132
1.64
1.24
1.4
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
37
2.20
1.22
3.0
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
176
1598
1.29
1.20
2.8
2.6
u/l
35.2
35.2
0.00
169
1518
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
246
0.59
1.20
7.8
4.8
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
20
2.53
1.15
10.4
2.0
u/ml
127.8
22.3
—
5
20
(3000330) Specific gravity of Urine by Test strip
13
74
1.80
1.08
3.4
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
61
490
1.32
1.06
1.4
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
22
2.30
1.04
1.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
109
0.45
1.03
1.0
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
34
253
1.39
0.96
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
72
852
0.79
0.95
2.5
3.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
52
1.76
0.93
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
52
1.76
0.93
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
86
1.66
0.93
1.1
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
31
229
1.40
0.92
1.5
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
204
2151
0.79
0.89
3.2
3.4
mmol/l
1.3
1.2
0.54
198
2033
(1761868) Lipid panel - Serum or Plasma
84
967
0.81
0.85
2.1
2.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
27
0.00
0.78
0.0
1.4
—
458.4
—
0
20
(3000492) Spirometry study
26
193
1.38
0.76
1.4
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
28
0.00
0.76
0.0
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
9
53
1.72
0.76
1.2
1.2
—
73.3
—
0
6
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
46
373
1.28
0.76
2.1
2.3
ng/l
493.8
588.0
0.18
39
306
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
18
125
1.47
0.75
3.3
2.9
ng/l
52.3
66.9
1.29
18
118
(4062490)
5
25
2.02
0.73
1.0
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
9
57
1.60
0.72
2.0
2.9
%
50.5
52.8
—
9
57
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
65
554
1.23
0.71
1.2
1.3
u/ml
0.7
2.0
—
9
170
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
26
1.94
0.71
1.2
1.4
—
—
—
0
0
(1002224) Polysomnography panel
16
110
1.48
0.70
1.1
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
69
1.62
0.69
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
27
1.87
0.69
2.8
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
57
669
0.81
0.69
2.7
2.6
ng/l
63.9
18.3
0.55
25
342
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
31
391
0.77
0.68
1.9
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
137
1.42
0.66
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
70
1.60
0.66
1.4
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
10
62
1.64
0.66
1.0
1.3
ug/g
251.0
316.3
—
5
30
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
191
1806
1.20
0.65
3.4
3.5
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
7.9
—
0.6
—
0
20
(3037756) Immunofixation for Serum or Plasma
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
173
0.68
0.60
1.0
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
3.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
64
1.58
0.59
2.0
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
158
1.36
0.59
4.8
2.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
73
1.53
0.57
1.4
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
36
1.68
0.57
1.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
82
1.49
0.55
1.8
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
29
232
1.28
0.55
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
217
2244
0.83
0.54
3.5
3.8
mmol/l
1.6
1.6
1.19
211
2127
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
19
143
1.35
0.54
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
19
143
1.35
0.54
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
19
143
1.35
0.54
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
19
143
1.35
0.54
1.2
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
39
1.55
0.53
1.5
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
197
1884
1.17
0.51
4.0
4.2
pmol/l
13.9
14.4
2.22
190
1767
(3041096) Erythrocytes [Presence] in Urine by Automated
54
618
0.84
0.50
2.0
2.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
20
154
1.32
0.50
13.7
14.6
inr
1.6
1.3
—
5
20
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
11
155
0.70
0.50
1.7
2.2
u/l
91.0
2195.0
—
6
61
(3020630) Protein [Mass/volume] in Serum or Plasma
7
109
0.63
0.49
2.3
2.1
g/l
62.7
69.1
—
7
103
(3019150) Specific gravity of Urine by Refractometry
41
479
0.83
0.48
2.6
3.2
kg/l
1.0
1.0
—
6
65
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
7
47
1.50
0.48
1.9
1.8
ug/l
263.6
168.6
—
7
42
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
68
1.49
0.47
1.3
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
7
50
1.41
0.45
1.0
2.0
g/l
2.0
1.3
—
7
44
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
19
148
1.31
0.45
1.2
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
56
494
1.17
0.44
1.4
1.3
g/l
1.8
2.1
1.37
27
318
(3023511) Choriogonadotropin [Units/volume] in Urine
6
93
0.64
0.43
1.3
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
33
389
0.83
0.43
1.3
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
32
1.57
0.42
1.2
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
15
0.00
0.41
0.0
1.3
—
33.5
—
0
15
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
15
0.00
0.41
0.0
2.3
—
816.2
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
159
0.74
0.39
1.5
1.2
—
55.7
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
5
35
1.44
0.39
4.0
3.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
225
2189
1.17
0.39
4.8
4.8
mu/l
1.8
2.3
0.47
217
2064
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
19
234
0.80
0.37
1.2
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
38
435
0.85
0.36
1.9
2.0
—
—
—
0
0
(3019225) pH of Specimen
14
177
0.78
0.34
4.8
3.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
30
345
0.85
0.31
1.2
1.4
titre
373.3
546.5
—
6
77
(3015736) pH of Urine
91
853
1.10
0.28
2.4
2.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
62
671
0.90
0.27
1.4
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
72
0.69
0.26
2.8
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
114
1084
1.09
0.26
2.7
3.1
estimate
0.0
0.0
—
6
191
(3037467) Urinalysis macro (dipstick) panel - Urine
154
1484
1.09
0.26
3.9
3.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
83
0.72
0.24
3.0
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
39
1.29
0.23
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
40
1.25
0.22
1.4
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
116
1.22
0.22
1.1
1.4
miu/ml
163.9
279.4
—
8
55
(46235355) HIV 1 and 2 tests - Meaningful Use set
64
597
1.09
0.22
1.6
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
13
156
0.82
0.22
2.8
2.9
—
—
—
0
0
(4211845)
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
1.9
—
0
10
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
2246.9
—
0
10
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
4.7
—
—
—
0
0
(4024509)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
9
114
0.78
0.20
6.0
4.4
ug/l
3.0
2.0
—
9
103
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
66
0.75
0.17
1.0
1.3
—
9.2
—
0
13
(3019060) Gas panel - Arterial blood
8
68
1.18
0.17
3.5
4.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
162
0.86
0.16
1.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
71
1.13
0.16
2.4
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
216
1.12
0.16
1.5
1.6
—
—
—
0
0
(4034850)
6
80
0.74
0.15
28.7
5.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
10
118
0.84
0.14
1.8
1.7
g/l
1.5
1.3
—
10
112
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
84
1.20
0.14
1.5
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
111
1076
1.05
0.13
4.2
4.3
estimate
0.0
0.0
—
8
199
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
202
1990
1.06
0.13
4.5
4.5
mmol/mol
38.8
38.3
0.37
195
1881
(3009508) Creatinine [Moles/volume] in Urine
50
527
0.94
0.12
3.3
2.9
mmol/l
6.7
7.6
0.59
42
458
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
343
0.92
0.12
1.4
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
279
1.08
0.11
1.4
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
164
1668
0.96
0.10
3.4
3.6
mm/h
9.4
9.6
0.15
158
1557
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
58
604
0.95
0.10
1.7
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
109
1063
1.04
0.10
2.7
3.1
estimate
0.0
0.0
—
8
196
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
145
0.89
0.09
1.3
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
87
1.16
0.09
1.4
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
11
124
0.88
0.09
1.3
1.4
mu/l
200.6
305.8
1.48
11
109
(3022621) pH of Urine by Test strip
14
126
1.12
0.09
2.8
2.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
97
1.14
0.09
1.7
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
214
2161
0.95
0.09
3.7
3.8
mmol/l
5.7
5.7
0.05
205
2030
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
65
0.76
0.08
1.0
1.3
—
3.2
—
0
8
(3045414) Leukocytes [Presence] in Urine
10
88
1.14
0.08
2.7
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
65
1.08
0.08
1.3
2.3
%
1.3
1.0
—
7
65
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
80
0.87
0.07
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
324
1.06
0.07
1.9
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
47
486
0.96
0.06
3.7
3.7
mg/mmol
3.1
7.0
1.36
23
293
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
597
1.03
0.04
1.7
1.6
mmol/l
1.4
1.4
0.17
56
520
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
219
0.96
0.03
1.3
1.2
iu/ml
142.3
161.1
—
10
96
(3008898) HLA-B27 [Presence]
13
138
0.94
0.02
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
35
343
1.02
0.01
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
104
1.06
0.01
1.7
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
104
1.06
0.01
1.7
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
166
0.96
0.00
1.1
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
47
464
1.02
0.00
1.3
1.3
u/ml
6.0
10.0
0.51
19
204
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
476
0.98
0.00
1.5
1.3
iu/ml
27.3
30.3
0.12
11
151
(3023520) Reticulocytes [#/volume] in Blood
10
102
0.98
0.00
1.5
2.4
e9/l
78.8
70.7
—
5
76
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
309
1.00
0.00
1.5
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
47
469
1.00
0.00
2.0
2.0
mg/l
2.3
2.8
0.98
39
406
(3027944) Amphetamines [Presence] in Urine
10
103
0.97
0.00
1.3
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
29
287
1.01
0.00
1.4
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
105
1.05
0.00
1.7
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
213
0.98
0.00
1.3
1.4
—
—
—
0
0
(4010399)
15
147
1.02
0.00
1.1
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
136
1.03
0.00
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
225
1.02
0.00
2.2
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
66
0.91
0.00
1.5
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
51
0.98
0.00
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
81
0.99
0.00
1.0
1.2
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
71
0.99
0.00
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
58
0.86
0.00
3.2
2.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
7
0.00
0.00
0.0
1.0
—
394.3
—
0
7
(3011897) Casein IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
33
330
1.00
0.00
1.9
2.3
ug/g
205.3
99.0
0.56
28
264
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
8
0.00
0.00
0.0
1.9
—
0.3
—
0
8
(42529406) Shigella sp [Presence] in Stool by Culture
8
83
0.96
0.00
1.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
9
0.00
0.00
0.0
2.3
—
1852.2
—
0
9
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.4
—
7.2
—
0
8
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
1.7
—
0
9
(4094501)
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
46
460
1.00
0.00
3.2
3.1
mg/l
20.2
358.2
0.89
27
289
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.9
—
8.0
—
0
7
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
3.0
—
0
9
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
62
0.97
0.00
1.0
1.2
—
15.8
—
0
6
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PROPHYLACT_SURGE – Prophylactic surgery
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).